Literature DB >> 25554622

Personality features in ultra-high risk for psychosis: a comparative study with schizophrenia and control subjects using the Temperament and Character Inventory-Revised (TCI-R).

Ana Fresán1, Pablo León-Ortiz2, Rebeca Robles-García3, Mariana Azcárraga4, Diana Guizar1, Francisco Reyes-Madrigal4, Carlos Alfonso Tovilla-Zárate5, Camilo de la Fuente-Sandoval6.   

Abstract

Several variables have been identified as risk factors for conversion to overt psychosis in ultra-high risk for psychosis (UHR) individuals. Although almost two-thirds of them do not experience a transition to psychosis, they still exhibit functional disabilities. Other subjective developmental features may be useful for a more precise identification of individuals at UHR. Avoidant behaviors are consistently reported in schizophrenia and in UHR individuals and may be the reflection of a pattern of personality. Thus, personality features in UHR individuals deserves further research. The objective of the present study was to compare temperament and character dimensions between UHR individuals, patients with schizophrenia and healthy controls. One hundred participants (25 UHR individuals, 25 schizophrenia patients and 50 control subjects) where evaluated with the Temperament and Character Inventory-Revised (TCI-R). Univariate ANOVAs followed by Bonferroni tests were used. UHR individuals and schizophrenia patients exhibited higher levels of Harm Avoidance (HA) when compared to control subjects. For HA1 Anticipatory worry vs Uninhibited optimism and HA4 Fatigability & asthenia, UHR and schizophrenia groups showed similar scores and both groups were higher compared to control subjects. With respect to Cooperativeness (CO), UHR and schizophrenia reported lower scores than control subjects, in particular CO2 Empathy vs Social disinterest and CO3 Helpfulness vs unhelpfulness. This study replicates and extends the consideration of HA as a psychopathological related endophenotype and gives us further information of the possible role of personality features in the expression of some of the social dysfunctions observed both in prodromal subjects and schizophrenia patients.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Character; Harm avoidance; Prodromal; Schizophrenia; Temperament; Ultra-high risk

Mesh:

Year:  2014        PMID: 25554622     DOI: 10.1016/j.jpsychires.2014.12.013

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  12 in total

1.  Temperament in child and adolescent offspring of patients with schizophrenia and bipolar disorder.

Authors:  Covadonga M Díaz-Caneja; Mª Goretti Morón-Nozaleda; Raquel P Vicente-Moreno; Elisa Rodríguez-Toscano; Laura Pina-Camacho; Elena de la Serna; Gisela Sugranyes; Inmaculada Baeza; Soledad Romero; Vanessa Sánchez-Gistau; Josefina Castro-Fornieles; Carmen Moreno; Dolores Moreno
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-03-08       Impact factor: 4.785

2.  Investigating the Impact of a Genome-Wide Supported Bipolar Risk Variant of MAD1L1 on the Human Reward System.

Authors:  Sarah Trost; Esther K Diekhof; Holger Mohr; Henning Vieker; Bernd Krämer; Claudia Wolf; Maria Keil; Peter Dechent; Elisabeth B Binder; Oliver Gruber
Journal:  Neuropsychopharmacology       Date:  2016-05-13       Impact factor: 7.853

3.  Association between neurological soft signs, temperament and character in patients with schizophrenia and non-psychotic relatives.

Authors:  Liliana Galindo; Francisco Pastoriza; Daniel Bergé; Anna Mané; Marisol Picado; Antonio Bulbena; Patricia Robledo; Victor Pérez; Oscar Vilarroya; Claude Robert Cloninger
Journal:  PeerJ       Date:  2016-04-26       Impact factor: 2.984

4.  Personality traits in established schizophrenia: aspects of usability and differences between patients and controls using the Swedish universities Scales of Personality.

Authors:  Tomas Fagerberg; Erik Söderman; J Petter Gustavsson; Ingrid Agartz; Erik G Jönsson
Journal:  Nord J Psychiatry       Date:  2016-04-22       Impact factor: 2.202

5.  Comorbidity of schizophrenia and social phobia - impact on quality of life, hope, and personality traits: a cross sectional study.

Authors:  Kristyna Vrbova; Jan Prasko; Marie Ociskova; Michaela Holubova
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-03       Impact factor: 2.570

6.  Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia.

Authors:  Juan L Molina; María Calvó; Eduardo Padilla; Mara Balda; Gabriela González Alemán; Néstor V Florenzano; Gonzalo Guerrero; Danielle Kamis; Beatriz Molina Rangeon; Mercedes Bourdieu; Sergio A Strejilevich; Horacio A Conesa; Javier I Escobar; Igor Zwir; C Robert Cloninger; Gabriel A de Erausquin
Journal:  NPJ Schizophr       Date:  2017-01-11

7.  Prediction of prodromal symptoms and schizophrenia-spectrum personality disorder traits by positive and negative schizotypy: A 3-year prospective study.

Authors:  Anna Racioppi; Tamara Sheinbaum; Georgina M Gross; Sergi Ballespí; Thomas R Kwapil; Neus Barrantes-Vidal
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

8.  Associations Of Personality Traits With The Capacity-Performance Discrepancy Of Functional Outcome In Patients With Schizophrenia.

Authors:  Takashi Uchino; Takahiro Nemoto; Taiju Yamaguchi; Naoyuki Katagiri; Naohisa Tsujino; Yoshitaka Murakami; Kuniaki Tanaka; Masafumi Mizuno
Journal:  Neuropsychiatr Dis Treat       Date:  2019-10-03       Impact factor: 2.570

9.  Protective Factors for Psychotic Symptoms Among Poly-victimized Children.

Authors:  Eloise Crush; Louise Arseneault; Sara R Jaffee; Andrea Danese; Helen L Fisher
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

10.  Heritability and Familiality of Temperament and Character Dimensions in Korean Families with Schizophrenic Linkage Disequilibrium.

Authors:  Byung Dae Lee; Je Min Park; Young Min Lee; Eunsoo Moon; Hee Jeong Jeong; Young In Chung; Young Mi Yi
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-05-31       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.